GREAT WEST LIFE ASSURANCE CO /CAN/ - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 103 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.

Quarter-by-quarter ownership
GREAT WEST LIFE ASSURANCE CO /CAN/ ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$14,000
-22.2%
2,0020.0%0.00%
Q2 2021$18,000
-5.3%
2,0020.0%0.00%
Q1 2021$19,000
-5.0%
2,0020.0%0.00%
Q4 2020$20,0000.0%2,0020.0%0.00%
Q3 2020$20,000
-4.8%
2,0020.0%0.00%
Q2 2020$21,000
+23.5%
2,0020.0%0.00%
Q1 2020$17,0000.0%2,0020.0%0.00%
Q4 2019$17,000
-64.6%
2,002
-47.0%
0.00%
Q2 2019$48,000
-67.1%
3,7740.0%0.00%
Q1 2019$146,000
+97.3%
3,7740.0%0.00%
Q4 2018$74,000
-57.2%
3,7740.0%0.00%
Q3 2018$173,000
-22.4%
3,7740.0%0.00%
-100.0%
Q2 2018$223,000
-13.2%
3,7740.0%0.00%0.0%
Q1 2018$257,000
-30.9%
3,7740.0%0.00%0.0%
Q4 2017$372,000
+5.7%
3,774
+25.4%
0.00%0.0%
Q3 2017$352,000
+34.4%
3,0090.0%0.00%0.0%
Q2 2017$262,000
+133.9%
3,0090.0%0.00%
Q1 2017$112,000
+20.4%
3,0090.0%0.00%
Q4 2016$93,000
-76.9%
3,009
-50.0%
0.00%
-100.0%
Q3 2016$402,000
+351.7%
6,018
+100.0%
0.00%
Q2 2016$89,000
+1.1%
3,0090.0%0.00%
Q1 2016$88,000
-62.7%
3,0090.0%0.00%
-100.0%
Q4 2015$236,000
-45.4%
3,009
-47.5%
0.00%
-50.0%
Q3 2015$432,000
+1.6%
5,728
+56.8%
0.00%
+100.0%
Q2 2015$425,000
-13.4%
3,652
+74.9%
0.00%
-50.0%
Q1 2015$491,000
+24.6%
2,0880.0%0.00%
+100.0%
Q4 2014$394,000
-21.2%
2,0880.0%0.00%
-50.0%
Q3 2014$500,000
+327.4%
2,088
+17.8%
0.00%
Q2 2014$117,0001,7720.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,536,156$21,405,0002.24%
Palo Alto Investors LP 1,396,163$11,784,0000.99%
Camber Capital Management LP 1,950,000$16,458,0000.98%
TANG CAPITAL MANAGEMENT LLC 800,000$6,752,0000.95%
Capital Impact Advisors, LLC 147,303$1,243,0000.52%
Sofinnova Investments, Inc. 638,026$5,385,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 963,212$8,130,0000.26%
RICE HALL JAMES & ASSOCIATES, LLC 466,482$3,937,0000.22%
PDT Partners, LLC 204,238$1,724,0000.14%
Eversept Partners, LP 58,251$491,6380.12%
View complete list of PUMA BIOTECHNOLOGY INC shareholders